Blink Charging Co (NASDAQ: BLNK): The company is an operator and provider of electric vehicle (EV) charging equipment and networked EV charging services.

• Negative Operating margin, EBITDA margin and Net Margin.
• Losses at the bottom line expanded in the quarter just gone by.
• Overvalued from Trailing Twelve Month Price/Book multiple standpoint
• Trading in Bearish Zone, with price closed below the crucial long-term and short-term support levels of 200-day and 50-day SMAs.

Conclusion: BLNK has poor fundamentals, with negative margin profile and expanding losses at the bottom line. Further, from technical standpoint, BLNK shares have charting in a long-term bearish zone, as its shares traded well below the short-term and long-term moving averages, and RSI at 33.2 indicating a weak momentum and traders are less interested in buying BLNK shares. Therefore, based on the above rationale we suggest a “Watch” recommendation on the stock at the closing price of USD 31.07 on July 19, 2021.Source: REFINITIV, Analysis by Kalkine Group

Fisker Inc (NYSE: FSR): Fisker Inc., formerly Spartan Energy Acquisition Corp., is an automotive company. The Company designs and manufactures electric vehicles.

• Reported negative ROE of 18% vs industry median of positive 3.4%
• Negative Operating margin, EBITDA margin and Net Margin whereas industry median is 10.9%, 7% and 5.9% respectively.
• Trading at overstretched valuation from TTM EV/Sales standpoint
• Negative spread between closing price and crucial support levels of 200-day and 50-day SMAs.
• RSI at 37.39 indicates bearish momentum in the stock.

Conclusion: The company has poor fundamentals with negative margin profile and poor return on shareholder’s money. Moreover, technically FSR shares are hovering in a bearish price zone, with 14-day RSI showing bearish momentum and stock hovering well below the crucial long-term as well as short-term support levels of 200-day and 50-day SMAs. Therefore, based on the above rationale, we recommend an “Avoid” rating on the stock at the closing price of USD 15.16 on July 19, 2021. Source: REFINITIV, Analysis by Kalkine Group

Schrodinger Inc (NASDAQ: SDGR): It provides computational software solutions for drug discovery to the biopharmaceutical industry.

• Negative Return on Asset
• Generating negative Return on Shareholder’s money.
• Negative Margin Profile, with reported EBITDA margin, Operating margin and Net Margin was in negative.
• A bullish Engulfing pattern appeared on the daily price chart.
• 14-day RSI also recovering and if it moves above 40, bearish trend can shift into consolidation zone.

Conclusion: Given the bullish engulfing pattern appeared on the daily price chart, and recovery in the RSI indicates for a potential trend shift in the stock. However, fundamentals of the group are not encouraging. Therefore, we recommend a “Watch” stance on the stock at the closing price of USD 68.56 on July 19, 2021.  

Source: REFINITIV, Analysis by Kalkine Group 

TG Therapeutics, Inc (NASDAQ: TGTX): The company is a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

• Negative EBITDA, Operating and Net Margin Profile
• Negative cash flow per share
• Generating negative return on the shareholder’s money
• Poor 5-year Sales growth negative 0.5%
• Negative Spread between last closing price and crucial support levels of 200-day SMA.
• MACD oscillator falling and hovering below the 9-day SMA signal line.

Conclusion: TGTX shares entered a bearish cycle with price moved below the crucial support level of 200-day SMAs. Moreover, the leading momentum indicator is falling with the spread between short-length 12-day EMA and 26-day EMA is negative, and MACD is hovering below the 9-day SMA signal line. Therefore, based on the above rationale, we recommend an “Avoid” rating on the stock at the closing price of USD 36.86 on July 19, 2021.

Source: REFINITIV, Analysis by Kalkine Group 

BEST Inc (NYSE: BEST): BEST Inc is a China-based holding company. The Company mainly conducts its business through its subsidiaries, variable interest entities (VIEs) and VIEs' subsidiaries.

• Stock trading below the downward sloping line.
• Negative spread between last closing price and 200-day SMA
• MACD is falling and hovering below the 9-day SMA signal line
• Negative Gross margin, EBITDA margin, Operating margin and Net margin
• Highly leveraged with total debt/equity ratio at the end of March 2021, stood at 4.90x, implies a higher balance sheet risk

Conclusion: BEST shares trading in a long-term bearish zone, with stock traded well below the long-term crucial support levels of 200-day SMA. Moreover, the company has significantly higher debt which poses strong balance sheet risks for the investors Therefore, we recommend an “Avoid” rating on the stock at the closing price of USD 1.28 on July 19, 2021.

Source: REFINITIV, Analysis by Kalkine Group

Keysight Technologies Inc (NYSE: KEYS): The company is a measurement company engaged in providing electronic design and test solutions to communications and electronics industries.

• Delivering a decent ROE of 22.65%, generating very solid return on shareholder’s equity.
• Generating Decent ROA of 10%.
• However, the leading momentum indicator the MACD is falling, and hovering below the 9-day SMA signal line.

Conclusion: Despite decent fundamental, KEYS shares trading at premium valuation, with TTM Price to Cash flow multiple of the company stood at 23.13x, whereas industry median is trading at 20.4x. This implies a premium valuation of approximately 12%. Given the recent consolidation in the market on the back of resurgence in COVID-19 cases, we believe valuation for many companies to consolidate. Therefore, we recommend a “Watch” stance on the stock at the closing price of USD 154.78 on July 19, 2021.

Source: REFINITIV, Analysis by Kalkine Group

*The reference data in this report has been partly sourced from REFINITIV.

Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine do not hold interests in any of the securities or other financial products covered on the Kalkine website.